These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21924046)

  • 1. [Current status and prospect of lung cancer gene therapy].
    Zu L; Liu H; Chen J; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):758-62. PubMed ID: 21924046
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesothelioma: an inviting but challenging target for gene therapy.
    Crystal RG
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):383-4. PubMed ID: 20228386
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application of target peptide in siRNA delivery 
for the research of lung cancer therapy].
    Gao H; Liu J; Song N
    Zhongguo Fei Ai Za Zhi; 2014 Sep; 17(9):674-8. PubMed ID: 25248709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for mesothelioma and lung cancer.
    Vachani A; Moon E; Wakeam E; Albelda SM
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):385-93. PubMed ID: 20160042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.
    Zarogouldis P; Karamanos NK; Porpodis K; Domvri K; Huang H; Hohenforst-Schimdt W; Goldberg EP; Zarogoulidis K
    Int J Mol Sci; 2012; 13(9):10828-10862. PubMed ID: 23109824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy.
    Hong SH; Park SJ; Lee S; Cho CS; Cho MH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
    Roth JA
    Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of oncolytic viruses to overcome lung cancer drug resistance.
    Beljanski V; Hiscott J
    Curr Opin Virol; 2012 Oct; 2(5):629-35. PubMed ID: 22910124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.
    Wei W; Mu Y; Li X; Gou M; Zhang H; Luo S; Men K; Mao Y; Qian Z; Yang L
    J Biomed Nanotechnol; 2011 Dec; 7(6):768-75. PubMed ID: 22416575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel amplifier expression vectors producing higher levels of IL-2 led to slower tumor growth and longer survival in vivo.
    Luo P; Tsang TC; He X; Gonzalez-Pena V; Jaramillo M; Takeuchi C; Harris DT
    DNA Cell Biol; 2005 Sep; 24(9):595-604. PubMed ID: 16153160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy as a novel treatment platform for cancer.
    Kirn D
    Ernst Schering Res Found Workshop; 2003; (43):89-105. PubMed ID: 12894453
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.
    Kita Y; Go T; Nakashima N; Liu D; Tokunaga Y; Zhang X; Nakano T; Nii K; Chang SS; Yokomise H
    Anticancer Res; 2020 Feb; 40(2):733-741. PubMed ID: 32014915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for lung cancer.
    Dubinett SM; Miller PW; Sharma S; Batra RK
    Hematol Oncol Clin North Am; 1998 Jun; 12(3):569-94. PubMed ID: 9684099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatility of gene therapy vectors through viruses.
    Barzon L; Stefani AL; Pacenti M; Palù G
    Expert Opin Biol Ther; 2005 May; 5(5):639-62. PubMed ID: 15934840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAC conditionally approves lung cancer gene therapy.
    Jenks S
    J Natl Cancer Inst; 1994 Jul; 86(13):964-5. PubMed ID: 8007017
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation of retroviral vectors for cell-cycle-targeted gene therapy of lung cancer.
    Claudio PP; Giordano A
    Methods Mol Med; 2003; 75():591-605. PubMed ID: 12407766
    [No Abstract]   [Full Text] [Related]  

  • 17. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
    Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus.
    Carbone DP; Minna JD
    J Natl Cancer Inst; 1994 Oct; 86(19):1437-8. PubMed ID: 8089857
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for lung neoplasms.
    Albelda SM; Wiewrodt R; Sterman DH
    Clin Chest Med; 2002 Mar; 23(1):265-77. PubMed ID: 11901916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein.
    Zhu B; Yang JR; Jiang YQ; Chen SF; Fu XP
    Cell Biochem Biophys; 2014 Jul; 69(3):583-7. PubMed ID: 24510538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.